Quarterly Financial Data (Unaudited)

12 Months Ended

Sep. 30, 2015

Quarterly Financial Information Disclosure [Abstract]

15. Quarterly Financial Data (Unaudited)

The following is a summary of the unaudited quarterly results for the years ended September 30, 2015 and 2014 (in thousands, except per share data).

	First Quarter		Second Quarter		Third Quarter			Fourth Quarter
Fiscal 2015
Total revenue	$	14,205	$	14,415	$	15,914		$	17,364
Operating income from continuing operations		5,034		3,932		5,857			4,266
Income from continuing operations		3,614		3,051		3,924			1,358
Loss from discontinued operations		—		—		—			—
Net income		3,614		3,051		3,924			1,358
Basic income (loss) per share(1):
Continuing operations		0.27		0.24		0.30			0.10
Discontinued operations		0.00		0.00		(0.00	)		(0.00	)
Net income		0.27		0.24		0.30			0.10
Diluted income (loss) per share(1):
Continuing operations		0.27		0.23		0.30			0.10
Discontinued operations		0.00		0.00		(0.00	)		(0.00	)
Net income		0.27		0.23		0.30			0.10

Fiscal 2014
Total revenue	$	13,883	$	13,604	$	14,616		$	15,336
Operating income from continuing operations		4,329		3,480		5,333			5,434
Income from continuing operations		3,630		2,459		3,674			2,444
Loss from discontinued operations		—		—		(76	)		(100	)
Net income		3,630		2,459		3,598			2,344
Basic income (loss) per share(1):
Continuing operations		0.26		0.18		0.27			0.18
Discontinued operations		0.00		0.00		(0.01	)		(0.01	)
Net income		0.26		0.18		0.26			0.17
Diluted income (loss) per share(1):
Continuing operations		0.26		0.18		0.27			0.18
Discontinued operations		0.00		0.00		(0.01	)		(0.01	)
Net income		0.26		0.18		0.26			0.17

(1)	The sum of the quarterly income (loss) per share amounts may not equal the annual income (loss) per share total because of changes in the weighted average number of shares outstanding that occurred during the year.

In the fourth quarter of fiscal 2015, the Company recorded expense related to the settlement of a claim of $2.5 million, a $1.5 million impairment loss on a strategic investment and recognized $0.8 million in previously contingent royalties.

In the third quarter of fiscal 2015, the Company recorded a $0.6 million one-time customer royalty payment related to periods prior to the third quarter fiscal 2015.

In the second quarter of fiscal 2015, the Company recorded a $0.5 million gain on a strategic investment in Intersect ENT shares.

In the fourth quarter of fiscal 2014, the Company recorded a $1.2 million impairment loss on strategic investments.

In the second quarter of fiscal 2014, the Company recorded a $0.9 million stock-based compensation expense related to modification of Board of Directors options and other equity awards vesting periods.

In the first quarter of fiscal 2014, the Company recorded a gain of $0.7 million associated with contingent consideration paid associated with the sale of a strategic investment.